Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CORT

“Cort really is to be congratulated once again for delivering onits Masterpiece promise”: Cort Abstract Delta and Modern Black review

Two acoustics from Cort’s China-based workshop that couldn’t be further apart in style, from the traditional overtones of the AbstractDelta, to the more contemporary Modern Black

Guitar World

James Earl Jones obituary

American actor hailed for his many classical roles whose voice became known to millions as that of Darth Vader in Star Wars

The Guardian - UK

“A value-conscious workhorse with premium features”: Cort adds the impressively spec’d, competitively priced G250 to its super-versatile G series of S-style electric guitars

Just $349 and you get an HSS bolt-on electric with a roasted maple neck, 2-point tremolo, and Cort's new Voiced Tone pickups with 5-way switching and coil-split

MusicRadar

From analysis to the latest developments in health,
read the most diverse news in one place.

2024 Summer Ultimate Gear Guide: the hottest new guitar gear of the year

A detailed rundown of the hottest guitar gear to hit the market over the past year. Here, we dive into the standout pieces.

Guitar World

Jasper Philipsen outsprints Wout van Aert to win stage 13 of the Tour de France in Pau

Philipsen takes second victory of the race ahead of Van Aert and Pascal Ackermann

Cycling Weekly

3 Biotech Stocks With Sky-High Price Targets

The biotech sector is primed for growth, fueled by numerous advancements in genetic engineering and rising investment in research and development of personalized medicine. Hence, quality biotech stocks, BioMarin Pharmaceutical (BMRN), Alnylam Pharmaceuticals (ALNY), and Corcept Therapeutics (CORT) with sky-high price targets might be solid buys. Read more….

StockNews.com

3 Biotech Stocks for Investing in the Future

The biotech sector is primed for robust expansion fueled by the growing needs for personalized medicines and favorable government initiatives. Amid this backdrop, investors could consider buying biotech stocks Esperion Therapeutics (ESPR), Corcept Therapeutics (CORT), and Shionogi (SGIOY). Keep reading.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Promising Biotech Stocks Driving Weekly Gains

The biotech industry’s prospects appear promising due to government support, regulatory changes, innovative therapies, and a focus on personalized medicine. Therefore, investors could consider buying fundamentally strong biotech stocks such as United Therapeutics (UTHR), TRACON Pharmaceuticals (TCON), and Corcept Therapeutics (CORT). Read more.

StockNews.com

Top 3 Biotech Stocks to Anchor Your Portfolio

Amid robust global medicine spending, surging biopharma M&A activity, and technological advancements, the biotech industry is set for significant growth this year and beyond. Given the industry’s bright prospects, top biotech stocks Corcept Therapeutics (CORT), Entrada Therapeutics (TRDA), and Exelixis (EXEL) might be ideal buys now to anchor one’s portfolio.…

StockNews.com

5 Easy Changes That Make Your Living Room More Low Maintenance

If keeping up with a tidy, clean living room is keeping you up at night, make these simple switches that will make it easier to reset every day

Livingetc

“It isn’t just a modern headless instrument; it’s a resurrection of a pioneering legacy”: Cort reinvents its “revolutionary” headless Artisan bass design with the upgraded Space 5 model

New five-string model pairs own-brand headless tech with refined sculpting for a compact and tonally balanced build

Guitar World

Plunge into Profits With These 3 Biotech Stocks

The biotech industry's robust growth potential is driven by substantial pharma research and development, swift technological advancements, and lucrative government support. Given this backdrop, quality biotech stocks ProQR Therapeutics N.V. (PRQR), Regeneron Pharmaceuticals (REGN), and Corcept Therapeutics (CORT) could be solid buys now. Read on….

StockNews.com

“A powerful monster primed to nail the expectations of even the most demanding metal guitarist”: Cort unveils the KX707 EverTune 7-string – adding an ash top and some choice tweaks to its beloved KX700

The brand is continuing its tradition of offering well-spec'd builds at affordable price points with a stealthy 7-string that comes loaded with Seymour Duncan Sentient and Nazgûl pickups

Guitar World

Is Cort's new KX707 the best value 7-string guitar with an Evertune bridge that you can buy right now?

It's right up there in the extended-range stakes… but not much of a change from the previous model

MusicRadar

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Elite 4 Biotech Stocks to Buy Now for Explosive Returns

With a wide range of applications across sectors, including health, agriculture, and industrial processing, rapid technological adoption, and government support, the biotech industry’s prospects appear promising. Thus, investors could consider buying biotech stocks Corcept Therapeutics (CORT), Jazz Pharmaceuticals (JAZZ), Incyte (INCY), and Exelixis (EXEL) for substantial gains. Read on….

Guitar World

“This innovative instrument transcends boundaries, offering a sonic palette that's as diverse as your musical vision”: Cort and Hedras collaborate once again for the Triality X700 – an HSS twist on the pair’s progressive playing platform

Following the Duality and Mutility, this new offering looks to stretch beyond metal and rock realms and cater directly to the gigging guitarist demanding a do-it-all workhorse

StockNews.com

3 Biotech Stocks to Buy for Investor Security

Despite macroeconomic challenges, the biotech industry thrives on innovation, demand, and technological breakthroughs. Therefore, fundamentally strong biotech stocks ANI Pharmaceuticals (ANIP), Vanda Pharmaceuticals (VNDA) and Corcept Therapeutics (CORT) might be ideal additions to your portfolio. Read on.

StockNews.com

3 A-Rated Biotech Stocks for Your 2024 Portfolio

Inelastic demand for healthcare products and services and the increasing government initiatives around the world are expected to boost the biotech industry. Therefore, it could be wise to buy fundamentally strong biotech stocks Entrada Therapeutics (TRDA), Corcept Therapeutics (CORT), and Alkermes (ALKS) this year. Read more.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Investors Keeping a Close Eye on These 3 Biotech Stocks

Growing adoption of AI technologies by biopharmaceutical companies and growing foothold of personalized medicine are expected to drive growth in the biotech market. Therefore, it could be wise to buy fundamentally strong biotech stocks Regeneron Pharmaceuticals (REGN), Corcept Therapeutics (CORT), and Incyte (INCY). Read more.

StockNews.com

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits.…

StockNews.com

Unlocking Biotech's Potential With 3 Stocks to Buy

The biotech industry’s growth is propelled by strong demand for medical support and interventions, favorable government initiatives, and rapid adoption of emerging technologies. Given the industry’s tailwinds, quality biotech stocks Shionogi (SGIOY), United Therapeutics (UTHR), and Corcept Therapeutics (CORT) could be ideal buys now. Read on….

StockNews.com

Which Stock Do Investors Consider a Heathier Investment: Bionano Genomics (BNGO) vs. Corcept Therapeutics (CORT)

The biotech industry is poised for long-term growth supported by government initiatives and the rising prevalence of chronic illnesses. While biotech stocks Bionano Genomics (BNGO) and Corcept Therapeutics (CORT) should benefit from the industry tailwinds, let us determine which stock could be considered a healthier investment.

StockNews.com

Time to Capitalize on These 3 Hot Biotech Stocks

The biotech industry is well-positioned for growth thanks to rising demand for quality healthcare, the prevalence of chronic diseases, and the government’s push to boost domestic biotech production and research. To that end, it could be wise to buy fundamentally strong biotech stocks Corcept Therapeutics (CORT), Ligand Pharmaceuticals (LGND), and…

StockNews.com

Are These 3 Biotech Stocks Good Buys?

Given that the biotech sector is rapidly expanding with robust demand, technology advancements, and government initiatives, fundamentally strong biotech stocks Incyte (INCY), Corcept Therapeutics (CORT), and Entrada Therapeutics (TRDA) look poised to generate significant returns. Hence, these stocks could be solid additions to your portfolio. Read on.

Guitar World

Cort G300 Glam and G300 Raw review

Cor-Tek might make a colossal number of guitars for other people, but its own brand, Cort, is gaining traction with sharply priced and very well-spec’d guitars such as this new G300 duo

1 2 3

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.